TWO · Financial Statements

DaBomb Protein Biotech Corp. (6578.TWO) Financial Statements

$16.90 TWO: 6578.TWO Market Cap $1.17B

Full income statement, balance sheet, and cash flow statement for DaBomb Protein Biotech Corp. (6578.TWO), plus valuation and return ratios.

Annual financials are not yet available for this stock.

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA47.97
FCF Yield—
Quick Ratio1.98
Interest Coverage—
Return 1Y-17.56%
Return 3Y5.50%
Return 5Y11.10%

DaBomb Protein Biotech Corp. (6578.TWO) financials — frequently asked questions

What is 6578.TWO EV/EBITDA?

DaBomb Protein Biotech Corp.'s enterprise value to EBITDA (EV/EBITDA) ratio is 47.97.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
6578.TWO Overview 6578.TWO Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.